EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SOX2 represses c-MYC transcription by altering the co-activator landscape of the c-MYC super-enhancer and promoter regions

Briana D Ormsbee Golden, Daisy V Gonzalez, Gregory S Yochum, Donald W Coulter, Angie Rizzino

Journal of Biological Chemistry · 2024-09 · 300 (9) · 107642

DOI: 10.1016/j.jbc.2024.107642 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024-09. Verfasst von Briana D Ormsbee Golden und 4 weiteren Autor:innen. Beteiligte Einrichtung: Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: SOXB1 Transcription Factors, Promoter Regions, Genetic, Proto-Oncogene Proteins c-myc, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Nebraska Department of Health and Human Services, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our previous studies determined that elevating SOX2 in a wide range of tumor cells leads to a reversible state of tumor growth arrest. Efforts to understand how tumor cell growth is inhibited led to the discovery of a SOX2:MYC axis that is responsible for downregulating c-MYC (MYC) when SOX2 is elevated. Although we had determined that elevating SOX2 downregulates MYC transcription, the mechanism responsible was not determined. Given the challenges of targeting MYC clinically, we set out to identify how elevating SOX2 downregulates MYC transcription. In this study, we focused on the MYC promoter region and an upstream region of the MYC locus that contains a MYC super-enhancer encompassing five MYC enhancers and which is associated with several cancers. Here we report that BRD4 and p300 associate with each of the MYC enhancers in the upstream MYC super-enhancer as well as the MYC promoter region and that elevating SOX2 decreases the recruitment of BRD4 and p300 to these sites. Additionally, we determined that elevating SOX2 leads to increases in the association of SOX2 and H3K27me3 within the MYC super-enhancer and the promoter region of MYC. Importantly, we conclude that the increases in SOX2 within the MYC super-enhancer precipitate a cascade of events that culminates in the repression of MYC transcription. Together, our studies identify a novel molecular mechanism able to regulate MYC transcription in two distinctly different tumor types and provide new mechanistic insights into the molecular interrelationships between two master regulators, SOX2 and MYC, widely involved in multiple cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SOXB1 Transcription FactorsPromoter Regions, GeneticProto-Oncogene Proteins c-mycTranscription FactorsEnhancer Elements, GeneticCell Cycle ProteinsTranscription, GeneticHumansCell Line, TumorGene Expression Regulation, NeoplasticNuclear ProteinsE1A-Associated p300 ProteinBromodomain Containing Proteins

Stichwörter der Autor:innen

A-485BRD4RNA polymerase IISOX2c-MYCcolorectal cancermedulloblastomap300super-enhancertranscription

Substanzen

SOXB1 Transcription FactorsProto-Oncogene Proteins c-mycSOX2 protein, humanTranscription FactorsBRD4 protein, humanCell Cycle ProteinsMYC protein, humanEP300 protein, humanNuclear ProteinsE1A-Associated p300 Protein

Autor:innen und Institutionen

  • Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Surgery & Biochemistry & Molecular Biology, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
  • Hematology and Oncology Division, Department of Pediatrics, Nebraska Medical Center, Omaha, Nebraska, USA; Child Health Research Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA; Fred & Pamela Buff…
  • Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA.…

Förderung

  • NCI NIH HHS
  • Nebraska Department of Health and Human Services
  • National Cancer Institute

Zitieren

APA

Ormsbee Golden, B. D., Gonzalez, D. V., Yochum, G. S., Coulter, D. W., & Rizzino, A. (2024). SOX2 represses c-MYC transcription by altering the co-activator landscape of the c-MYC super-enhancer and promoter regions. Journal of Biological Chemistry, 300(9), 107642. https://doi.org/10.1016/j.jbc.2024.107642

Vancouver

Ormsbee Golden BD, Gonzalez DV, Yochum GS, Coulter DW, Rizzino A. SOX2 represses c-MYC transcription by altering the co-activator landscape of the c-MYC super-enhancer and promoter regions. Journal of Biological Chemistry. 2024;300(9):107642. doi:10.1016/j.jbc.2024.107642

BibTeX
@article{OrmsbeeGolden2024,
  author = {Ormsbee Golden, Briana D and Gonzalez, Daisy V and Yochum, Gregory S and Coulter, Donald W and Rizzino, Angie},
  title = {SOX2 represses c-MYC transcription by altering the co-activator landscape of the c-MYC super-enhancer and promoter regions},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  volume = {300},
  number = {9},
  pages = {107642},
  doi = {10.1016/j.jbc.2024.107642}
}
Kostenlos starten →